Dual biological effects of the cytokines interleukin-10 and interferon-γ

Cancer Immunology, Immunotherapy

Volumn 60, Issue 11, 2011, Pages 1529-1541

  Wilke, Cailin Moira ^a,b   Wei, Shuang ^a   Wang, Lin ^a,c   Kryczek, Ilona ^a   Kao, John ^a,d   Zou, Weiping ^a,b,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

B7 H1; Cancer; IFN ; IL 10; Inflammation; Regulatory T cell

Indexed keywords

ARGINASE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROGRAMMED DEATH 1 LIGAND 1; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T CELL DEPLETION; T LYMPHOCYTE; TH17 CELL; TUMOR IMMUNITY;

ANIMALS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; NEOPLASMS;

EID: 82355175850     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1104-5     Document Type: Article

References (170)

1. DF Fiorentino MW Bond TR Mosmann 1989 Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J Exp Med 170 6 2081 2095 2531194 1:CAS:528:DyaK3cXhtFKqtL0%3D 10.1084/jem.170.6.2081 (Pubitemid 20010086)
2. A O'Garra G Stapleton V Dhar M Pearce J Schumacher H Rugo D Barbis A Stall J Cupp K Moore, et al. 1990 Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10 Int Immunol 2 9 821 832 1703785 10.1093/intimm/2.9.821 (Pubitemid 20307067)
3. SJ Galli J Kalesnikoff MA Grimbaldeston AM Piliponsky CM Williams M Tsai 2005 Mast cells as "tunable" effector and immunoregulatory cells: recent advances Annu Rev Immunol 23 749 786 15771585 1:CAS:528: DC%2BD2MXktFOju70%3D 10.1146/annurev.immunol.21.120601.141025 (Pubitemid 40563184)
4. MA Grimbaldeston S Nakae J Kalesnikoff M Tsai SJ Galli 2007 Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B Nat Immunol 8 10 1095 1104 17767162 1:CAS:528:DC%2BD2sXhtVCkurnL 10.1038/ni1503 (Pubitemid 47423757)
5. S Wei I Kryczek L Zou B Daniel P Cheng P Mottram T Curiel A Lange W Zou 2005 Plasmacytoid dendritic cells induce CD8 + regulatory T cells in human ovarian carcinoma Cancer Res 65 12 5020 5026 15958543 1:CAS:528: DC%2BD2MXltFemtLg%3D 10.1158/0008-5472.CAN-04-4043 (Pubitemid 40827308)
6. C Asseman S Mauze MW Leach RL Coffman F Powrie 1999 An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation J Exp Med 190 7 995 1004 10510089 1:CAS:528:DyaK1MXmsVClt7s%3D 10.1084/jem.190.7.995 (Pubitemid 29480828)
7. MJ McGeachy KS Bak-Jensen Y Chen CM Tato W Blumenschein T McClanahan DJ Cua 2007 TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology Nat Immunol 8 12 1390 1397 17994024 1:CAS:528:DC%2BD2sXhtlajtr7K 10.1038/ni1539 (Pubitemid 350138974)
8. H Jonuleit E Schmitt G Schuler J Knop AH Enk 2000 Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells J Exp Med 192 9 1213 1222 11067871 1:CAS:528:DC%2BD3cXnvFWgt74%3D 10.1084/jem.192.9.1213
9. UY Khoo IE Proctor AJ Macpherson 1997 CD4 + T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens J Immunol 158 8 3626 3634 9103424 1:CAS:528:DyaK2sXisFCitLc%3D (Pubitemid 127488715)
10. KN Couper DG Blount EM Riley 2008 IL-10: the master regulator of immunity to infection J Immunol 180 9 5771 5777 18424693 1:CAS:528:DC%2BD1cXkvVequ7o%3D
11. KW Moore R de Waal Malefyt RL Coffman A O'Garra 2001 Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 683 765 11244051 1:CAS:528:DC%2BD3MXivFKgu70%3D 10.1146/annurev.immunol.19.1.683 (Pubitemid 32368050)
12. DM Mosser X Zhang 2008 Interleukin-10: new perspectives on an old cytokine Immunol Rev 226 205 218 19161426 1:CAS:528:DC%2BD1MXhsFGls7%2FP 10.1111/j.1600-065X.2008.00706.x
13. R de Waal Malefyt J Haanen H Spits MG Roncarolo A te Velde C Figdor K Johnson R Kastelein H Yssel JE de Vries 1991 Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression J Exp Med 174 4 915 924 1655948 10.1084/jem.174.4.915
14. L Ding PS Linsley LY Huang RN Germain EM Shevach 1993 IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression J Immunol 151 3 1224 1234 7687627 1:CAS:528:DyaK3sXmt1eqsLg%3D (Pubitemid 23219258)
15. TJ Curiel S Wei H Dong X Alvarez P Cheng P Mottram R Krzysiek KL Knutson B Daniel MC Zimmermann O David M Burow A Gordon N Dhurandhar L Myers R Berggren A Hemminki RD Alvarez D Emilie DT Curiel L Chen W Zou 2003 Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity Nat Med 9 5 562 567 12704383 1:CAS:528:DC%2BD3sXjtlamtLc%3D 10.1038/nm863 (Pubitemid 36597102)
16. L Schandene C Alonso-Vega F Willems C Gerard A Delvaux T Velu R Devos M de Boer M Goldman 1994 B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10 J Immunol 152 9 4368 4374 7512591 1:CAS:528:DyaK2cXivFKntrg%3D
17. A Joss M Akdis A Faith K Blaser CA Akdis 2000 IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway Eur J Immunol 30 6 1683 1690 10898505 1:CAS:528:DC%2BD3cXktFWmurs%3D 10.1002/1521-4141(200006)30: 6<1683::AID-IMMU1683>3.0.CO;2-A (Pubitemid 30342811)
18. C Demangel P Bertolino WJ Britton 2002 Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production Eur J Immunol 32 4 994 1002 11920565 1:CAS:528:DC%2BD38XjtFWntb4%3D 10.1002/1521-4141(200204)32: 4<994::AID-IMMU994>3.0.CO;2-6 (Pubitemid 34428814)
19. W Zou 2006 Regulatory T cells, tumour immunity and immunotherapy Nat Rev Immunol 6 4 295 307 16557261 1:CAS:528:DC%2BD28XivVyru7k%3D 10.1038/nri1806
20. M Murai O Turovskaya G Kim R Madan CL Karp H Cheroutre M Kronenberg 2009 Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis Nat Immunol 10 11 1178 1184 19783988 1:CAS:528:DC%2BD1MXhtFygsLbJ 10.1038/ni.1791
21. R Kuhn J Lohler D Rennick K Rajewsky W Muller 1993 Interleukin-10- deficient mice develop chronic enterocolitis Cell 75 2 263 274 8402911 1:STN:280:DyaK2c%2Fgs1Gmug%3D%3D 10.1016/0092-8674(93)80068-P (Pubitemid 23320290)
22. NJ Davidson MW Leach MM Fort L Thompson-Snipes R Kuhn W Muller DJ Berg DM Rennick 1996 T helper cell 1-type CD4 + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice J Exp Med 184 1 241 251 8691138 1:CAS:528:DyaK28Xkt1ajsb8%3D 10.1084/jem.184.1.241 (Pubitemid 26247233)
23. P Zhou C Streutker R Borojevic Y Wang K Croitoru 2004 IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathy Am J Physiol Gastrointest Liver Physiol 287 3 G599 G604 15331352 1:CAS:528:DC%2BD2cXnvVeis74%3D 10.1152/ajpgi.00063.2004 (Pubitemid 39096626)
24. A Jarry C Bossard C Bou-Hanna D Masson E Espaze MG Denis CL Laboisse 2008 Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants J Clin Invest 118 3 1132 1142 18259614 1:CAS:528:DC%2BD1cXivFemsbw%3D (Pubitemid 351364620)
25. A Hagenbaugh S Sharma SM Dubinett SH Wei R Aranda H Cheroutre DJ Fowell S Binder B Tsao RM Locksley KW Moore M Kronenberg 1997 Altered immune responses in interleukin 10 transgenic mice J Exp Med 185 12 2101 2110 9182682 1:CAS:528:DyaK2sXktVeltLw%3D 10.1084/jem.185.12.2101 (Pubitemid 27265994)
26. N Peters D Sacks 2006 Immune privilege in sites of chronic infection: Leishmania and regulatory T cells Immunol Rev 213 159 179 16972903 1:CAS:528:DC%2BD28XhtF2lsrbF 10.1111/j.1600-065X.2006.00432.x (Pubitemid 44401500)
27. KF van der Sluijs LJ van Elden M Nijhuis R Schuurman JM Pater S Florquin M Goldman HM Jansen R Lutter T van der Poll 2004 IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection J Immunol 172 12 7603 7609 15187140 (Pubitemid 38747624)
28. P Jimenez Mdel L Walls J Fierer 2006 High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression Infect Immun 74 6 3387 3395 16714569 10.1128/IAI.01985-05 1:CAS:528:DC%2BD28Xlt1Cgu7w%3D (Pubitemid 43794529)
29. J Fierer L Walls L Eckmann T Yamamoto TN Kirkland 1998 Importance of interleukin-10 in genetic susceptibility of mice to Coccidioides immitis Infect Immun 66 9 4397 4402 9712793 1:CAS:528:DyaK1cXlslCrtb8%3D (Pubitemid 28402717)
30. JP Kelly GJ Bancroft 1996 Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes Eur J Immunol 26 2 356 364 8617304 1:STN:280:DyaK283gs1Wguw%3D%3D 10.1002/eji.1830260214 (Pubitemid 26060242)
31. BG Kim HG Joo IS Chung HY Chung HJ Woo YS Yun 2000 Inhibition of interleukin-10 (IL-10) production from MOPC 315 tumor cells by IL-10 antisense oligodeoxynucleotides enhances cell-mediated immune responses Cancer Immunol Immunother 49 8 433 440 11043850 1:CAS:528:DC%2BD3cXnsF2nsbk%3D 10.1007/s002620000123
32. P Matar VR Rozados SI Gervasoni OG Scharovsky 2001 Down regulation of T-cell-derived IL-10 production by low-dose cyclophosphamide treatment in tumor-bearing rats restores in vitro normal lymphoproliferative response Int Immunopharmacol 1 2 307 319 11360931 1:CAS:528:DC%2BD3MXhtlGitr4%3D 10.1016/S1567-5769(00)00028-X (Pubitemid 32183729)
33. AP Vicari C Chiodoni C Vaure S Ait-Yahia C Dercamp F Matsos O Reynard C Taverne P Merle MP Colombo A O'Garra G Trinchieri C Caux 2002 Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody J Exp Med 196 4 541 549 12186845 1:CAS:528:DC%2BD38XmsV2htbo%3D 10.1084/jem.20020732
34. AH Enk H Jonuleit J Saloga J Knop 1997 Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma Int J Cancer 73 3 309 316 9359474 1:CAS:528:DyaK2sXnslOisb0%3D 10.1002/(SICI)1097-0215(19971104)73:3<309::AID- IJC1>3.0.CO;2-3 (Pubitemid 27508890)
35. AE Loercher MA Nash JJ Kavanagh CD Platsoucas RS Freedman 1999 Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells J Immunol 163 11 6251 6260 10570318 1:CAS:528:DyaK1MXns12rtL8%3D
36. C De Santo R Arscott S Booth I Karydis M Jones R Asher M Salio M Middleton V Cerundolo 2010 Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A Nat Immunol 11 11 1039 1046 20890286 10.1038/ni.1942 1:CAS:528:DC%2BC3cXht1elu7rJ
37. N Seo S Hayakawa Y Tokura 2002 Mechanisms of immune privilege for tumor cells by regulatory cytokines produced by innate and acquired immune cells Semin Cancer Biol 12 4 291 300 12147203 1:CAS:528:DC%2BD38XlvVSjsLg%3D 10.1016/S1044-579X(02)00015-9 (Pubitemid 35034573)
38. M Kurte M Lopez A Aguirre A Escobar JC Aguillon J Charo CG Larsen R Kiessling F Salazar-Onfray 2004 A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and transporter associated with antigen processing 1/2 in human melanoma cells J Immunol 173 3 1731 1737 15265902 1:CAS:528:DC%2BD2cXlvVajs7g%3D (Pubitemid 38971604)
39. J Kim RL Modlin RL Moy SM Dubinett T McHugh BJ Nickoloff K Uyemura 1995 IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response J Immunol 155 4 2240 2247 7636270 1:CAS:528:DyaK2MXnsVShsLo%3D
40. K Steinbrink H Jonuleit G Muller G Schuler J Knop AH Enk 1999 Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells Blood 93 5 1634 1642 10029592 1:CAS:528:DyaK1MXhsFeru7g%3D (Pubitemid 29102491)
41. M Urosevic R Dummer 2003 HLA-G and IL-10 expression in human cancer-different stories with the same message Semin Cancer Biol 13 5 337 342 14708713 1:CAS:528:DC%2BD3sXptVCntrg%3D 10.1016/S1044-579X(03)00024-5 (Pubitemid 38160932)
42. VM Jovasevic L Gorelik JA Bluestone MB Mokyr 2004 Importance of IL-10 for CTLA-4-mediated inhibition of tumor-eradicating immunity J Immunol 172 3 1449 1454 14734721 1:CAS:528:DC%2BD2cXptlyrsg%3D%3D (Pubitemid 38116787)
43. M Huang M Stolina S Sharma JT Mao L Zhu PW Miller J Wollman H Herschman SM Dubinett 1998 Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production Cancer Res 58 6 1208 1216 9515807 1:CAS:528:DyaK1cXhvV2rs7w%3D (Pubitemid 28183210)
44. M Stolina S Sharma Y Lin M Dohadwala B Gardner J Luo L Zhu M Kronenberg PW Miller J Portanova JC Lee SM Dubinett 2000 Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis J Immunol 164 1 361 370 10605031 1:CAS:528:DC%2BD3cXisFSr (Pubitemid 30013010)
45. S Sharma M Stolina SC Yang F Baratelli JF Lin K Atianzar J Luo L Zhu Y Lin M Huang M Dohadwala RK Batra SM Dubinett 2003 Tumor cyclooxygenase 2-dependent suppression of dendritic cell function Clin Cancer Res 9 3 961 968 12631593 1:CAS:528:DC%2BD3sXhvFKiurY%3D (Pubitemid 36323698)
46. NF Go BE Castle R Barrett R Kastelein W Dang TR Mosmann KW Moore M Howard 1990 Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells J Exp Med 172 6 1625 1631 2124252 1:CAS:528:DyaK3cXmtV2ks7g%3D 10.1084/jem.172.6.1625
47. F Rousset E Garcia T Defrance C Peronne N Vezzio DH Hsu R Kastelein KW Moore J Banchereau 1992 Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes Proc Natl Acad Sci USA 89 5 1890 1893 1371884 1:CAS:528:DyaK38Xhslajtr4%3D 10.1073/pnas.89.5.1890
48. L Llorente W Zou Y Levy Y Richaud-Patin J Wijdenes J Alcocer-Varela B Morel-Fourrier JC Brouet D Alarcon-Segovia P Galanaud D Emilie 1995 Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus J Exp Med 181 3 839 844 7869046 1:STN:280:DyaK2M7ntlGquw%3D%3D 10.1084/jem.181.3.839
49. Y Levy JC Brouet 1994 Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein J Clin Invest 93 1 424 428 8282815 1:CAS:528:DyaK2cXitFGjsbo%3D 10.1172/JCI116977 (Pubitemid 24030864)
50. YJ Liu DY Mason GD Johnson S Abbot CD Gregory DL Hardie J Gordon IC MacLennan 1991 Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis Eur J Immunol 21 8 1905 1910 1868875 1:CAS:528:DyaK3MXmtlShurk%3D 10.1002/eji.1830210819
51. IA MacNeil T Suda KW Moore TR Mosmann A Zlotnik 1990 IL-10, a novel growth cofactor for mature and immature T cells J Immunol 145 12 4167 4173 2124236 1:STN:280:DyaK3M%2FnvFCquw%3D%3D
52. WF Chen A Zlotnik 1991 IL-10: a novel cytotoxic T cell differentiation factor J Immunol 147 2 528 534 1906502 1:CAS:528:DyaK3MXlvVWisL0%3D
53. S Mocellin FM Marincola HA Young 2005 Interleukin-10 and the immune response against cancer: a counterpoint J Leukoc Biol 78 5 1043 1051 16204623 1:CAS:528:DC%2BD2MXht1ShsL%2FN 10.1189/jlb.0705358 (Pubitemid 41572467)
54. T Suzuki H Tahara S Narula KW Moore PD Robbins MT Lotze 1995 Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors J Exp Med 182 2 477 486 7629507 1:CAS:528:DyaK2MXntFKhsLw%3D 10.1084/jem.182.2.477
55. LM Zheng DM Ojcius F Garaud C Roth E Maxwell Z Li H Rong J Chen XY Wang JJ Catino I King 1996 Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism J Exp Med 184 2 579 584 8760811 1:CAS:528: DyaK28XltVCrsL8%3D 10.1084/jem.184.2.579 (Pubitemid 26324111)
56. N Kundu AM Fulton 1997 Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis Cell Immunol 180 1 55 61 9316639 1:CAS:528:DyaK2sXmtlOlsLo%3D 10.1006/cimm.1997.1176 (Pubitemid 27433618)
57. K Karre 1993 Natural killer cells and the MHC class I pathway of peptide presentation Semin Immunol 5 2 127 145 8504217 1:STN:280:DyaK3s3nvVShtw%3D%3D 10.1006/smim.1993.1016
58. S Fujii K Shimizu T Shimizu MT Lotze 2001 Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ Blood 98 7 2143 2151 11568001 1:CAS:528:DC%2BD3MXnsVChtr0%3D 10.1182/blood.V98.7.2143
59. Tanikawa T, Wilke CM, Kryczek I, Chen GY, Kao JY, Zou W (2011) Ablation of interleukin (IL)-10 promotes tumor development, growth and metastasis (in press)
60. Z Zhou X Peng R Insolera DJ Fink M Mata 2009 Interleukin-10 provides direct trophic support to neurons J Neurochem 110 5 1617 1627 19575707 1:CAS:528:DC%2BD1MXhtVyntbrN 10.1111/j.1471-4159.2009.06263.x
61. HJ Park SJ Lee SH Kim J Han J Bae SJ Kim CG Park T Chun 2011 IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3 K) pathway Mol Immunol 48 4 720 727 21095008 1:CAS:528:DC%2BC3MXjsFWj 10.1016/j.molimm.2010.10.020
62. DS Dace AA Khan J Kelly RS Apte 2008 Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development PLoS One 3 10 e3381 18852882 10.1371/journal.pone.0003381 1:CAS:528: DC%2BD1cXhtlChtLnE
63. A Isaacs J Lindenmann 1957 Virus interference. I. The interferon Proc R Soc Lond B Biol Sci 147 927 258 267 13465720 1:STN:280:DyaG1c%2FgvVekuw%3D%3D 10.1098/rspb.1957.0048
64. A Isaacs J Lindenmann RC Valentine 1957 Virus interference. II. Some properties of interferon Proc R Soc Lond B Biol Sci 147 927 268 273 13465721 1:STN:280:DyaG1c%2FgvVersg%3D%3D 10.1098/rspb.1957.0049
65. T Yoshimoto K Takeda T Tanaka K Ohkusu S Kashiwamura H Okamura S Akira K Nakanishi 1998 IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production J Immunol 161 7 3400 3407 9759857 1:CAS:528:DyaK1cXmsFWmtr0%3D
66. M Munder M Mallo K Eichmann M Modolell 1998 Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation J Exp Med 187 12 2103 2108 9625771 1:CAS:528:DyaK1cXktVemur8%3D 10.1084/jem.187.12.2103 (Pubitemid 28285581)
67. K Tominaga T Yoshimoto K Torigoe M Kurimoto K Matsui T Hada H Okamura K Nakanishi 2000 IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells Int Immunol 12 2 151 160 10653850 1:CAS:528: DC%2BD3cXhsVyhsb8%3D 10.1093/intimm/12.2.151 (Pubitemid 30088307)
68. H Okamura H Tsutsi T Komatsu M Yutsudo A Hakura T Tanimoto K Torigoe T Okura Y Nukada K Hattori, et al. 1995 Cloning of a new cytokine that induces IFN-gamma production by T cells Nature 378 6552 88 91 7477296 1:CAS:528:DyaK2MXptVyqs74%3D 10.1038/378088a0
69. D Robinson K Shibuya A Mui F Zonin E Murphy T Sana SB Hartley S Menon R Kastelein F Bazan A O'Garra 1997 IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB Immunity 7 4 571 581 9354477 1:CAS:528:DyaK2sXntVWisLs%3D 10.1016/S1074-7613(00)80378-7 (Pubitemid 27508708)
70. T Yoshimoto H Okamura YI Tagawa Y Iwakura K Nakanishi 1997 Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells Proc Natl Acad Sci USA 94 8 3948 3953 9108085 1:CAS:528:DyaK2sXis1eisLo%3D 10.1073/pnas.94.8.3948 (Pubitemid 27180479)
71. GP Dunn CM Koebel RD Schreiber 2006 Interferons, immunity and cancer immunoediting Nat Rev Immunol 6 11 836 848 17063185 1:CAS:528:DC%2BD28XhtFWns7fK 10.1038/nri1961 (Pubitemid 44631652)
72. T Blankenstein Z Qin 2003 Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance Adv Cancer Res 90 179 207 14710951 1:CAS:528:DC%2BD2cXhvFaqtrk%3D 10.1016/S0065-230X(03)90006-6 (Pubitemid 37549225)
73. D Wallach M Fellous M Revel 1982 Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells Nature 299 5886 833 836 6290893 1:CAS:528:DyaL3sXhvFKitbs%3D 10.1038/299833a0 (Pubitemid 12003304)
74. DR Johnson JS Pober 1990 Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy- and light-chain genes in vascular endothelium Proc Natl Acad Sci USA 87 13 5183 5187 2164225 1:CAS:528:DyaK3cXkvFGqsLg%3D 10.1073/pnas.87.13.5183 (Pubitemid 20224297)
75. A Billiau H Heremans F Vandekerckhove R Dijkmans H Sobis E Meulepas H Carton 1988 Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma J Immunol 140 5 1506 1510 3126227 1:CAS:528:DyaL1cXhs1Gqtr8%3D
76. B Mach V Steimle E Martinez-Soria W Reith 1996 Regulation of MHC class II genes: lessons from a disease Annu Rev Immunol 14 301 331 8717517 1:CAS:528:DyaK28XitlCgtLk%3D 10.1146/annurev.immunol.14.1.301 (Pubitemid 26130187)
77. M Groettrup S Khan K Schwarz G Schmidtke 2001 Interferon-gamma inducible exchanges of 20S proteasome active site subunits: why? Biochimie 83 3-4 367 372 11295499 1:CAS:528:DC%2BD3MXivFKgsro%3D 10.1016/S0300-9084(01)01251-2 (Pubitemid 32293659)
78. CF Nathan HW Murray ME Wiebe BY Rubin 1983 Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity J Exp Med 158 3 670 689 6411853 1:CAS:528:DyaL3sXlt1SmsbY%3D 10.1084/jem.158.3.670 (Pubitemid 13051337)
79. L Flaishon R Hershkoviz F Lantner O Lider R Alon Y Levo RA Flavell I Shachar 2000 Autocrine secretion of interferon gamma negatively regulates homing of immature B cells J Exp Med 192 9 1381 1388 11067886 1:CAS:528: DC%2BD3cXnvFWgtLs%3D 10.1084/jem.192.9.1381
80. FD Finkelman IM Katona TR Mosmann RL Coffman 1988 IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses J Immunol 140 4 1022 1027 3125247 1:CAS:528:DyaL1cXhs1GrtLs%3D (Pubitemid 18088561)
81. F Balkwill J Taylor-Papadimitriou 1978 Interferon affects both G1 and S + G2 in cells stimulated from quiescence to growth Nature 274 5673 798 800 683317 1:CAS:528:DyaE1MXhtVWktLw%3D 10.1038/274798a0 (Pubitemid 8406161)
82. J Xaus M Cardo AF Valledor C Soler J Lloberas A Celada 1999 Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis Immunity 11 1 103 113 10435583 1:CAS:528:DyaK1MXltFCgt78%3D 10.1016/S1074-7613(00)80085-0 (Pubitemid 29359961)
83. M Shiohara K Koike T Nakahata 1993 Synergism of interferon-gamma and stem cell factor on the development of murine hematopoietic progenitors in serum-free culture Blood 81 6 1435 1441 7680916 1:CAS:528:DyaK3sXitFWisro%3D (Pubitemid 23083820)
84. TF Gajewski FW Fitch 1988 Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones J Immunol 140 12 4245 4252 2967332 1:CAS:528:DyaL1cXksFaqs78%3D
85. A Yoshida Y Koide M Uchijima TO Yoshida 1994 IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774 Biochem Biophys Res Commun 198 3 857 861 7906942 1:CAS:528:DyaK2cXhs1Wgtrs%3D 10.1006/bbrc.1994.1122
86. I Kryczek S Wei W Gong X Shu W Szeliga L Vatan L Chen G Wang W Zou 2008 Cutting edge: IFN-gamma enables APC to promote memory Th17 and abate Th1 cell development J Immunol 181 9 5842 5846 18941172 1:CAS:528:DC%2BD1cXht1Krtr3O
87. W Zou NP Restifo 2010 T(H)17 cells in tumour immunity and immunotherapy Nat Rev Immunol 10 4 248 256 20336152 1:CAS:528:DC%2BC3cXjvVGlt7k%3D 10.1038/nri2742
88. I Kryczek AT Bruce JE Gudjonsson A Johnston A Aphale L Vatan W Szeliga Y Wang Y Liu TH Welling JT Elder W Zou 2008 Induction of IL-17 + T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis J Immunol 181 7 4733 4741 18802076 1:CAS:528:DC%2BD1cXhtFarurrP
89. Feng T, Qin H, Wang L, Benveniste EN, Elson CO, Cong Y (2011) Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. J Immunol
90. S Huang W Hendriks A Althage S Hemmi H Bluethmann R Kamijo J Vilcek RM Zinkernagel M Aguet 1993 Immune response in mice that lack the interferon-gamma receptor Science 259 5102 1742 1745 8456301 1:CAS:528:DyaK3sXhvV2ksbg%3D 10.1126/science.8456301 (Pubitemid 23114659)
91. E Cantin B Tanamachi H Openshaw 1999 Role for gamma interferon in control of herpes simplex virus type 1 reactivation J Virol 73 4 3418 3423 10074196 1:CAS:528:DyaK1MXhvFynu7w%3D (Pubitemid 29135735)
92. U Muller U Steinhoff LF Reis S Hemmi J Pavlovic RM Zinkernagel M Aguet 1994 Functional role of type I and type II interferons in antiviral defense Science 264 5167 1918 1921 8009221 1:STN:280:DyaK2c3nvVCqtg%3D%3D 10.1126/science.8009221 (Pubitemid 24245635)
93. M Levin MJ Newport S D'Souza P Kalabalikis IN Brown HM Lenicker PV Agius EG Davies A Thrasher N Klein, et al. 1995 Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 345 8942 79 83 7815885 1:STN:280:DyaK2M7hsFCqtg%3D%3D 10.1016/S0140-6736(95)90059-4
94. MJ Newport CM Huxley S Huston CM Hawrylowicz BA Oostra R Williamson M Levin 1996 A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection N Engl J Med 335 26 1941 1949 8960473 1:CAS:528:DyaK2sXivVajsg%3D%3D 10.1056/NEJM199612263352602 (Pubitemid 26428218)
95. E Jouanguy S Lamhamedi-Cherradi D Lammas SE Dorman MC Fondaneche S Dupuis R Doffinger F Altare J Girdlestone JF Emile H Ducoulombier D Edgar J Clarke VA Oxelius M Brai V Novelli K Heyne A Fischer SM Holland DS Kumararatne RD Schreiber JL Casanova 1999 A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection Nat Genet 21 4 370 378 10192386 1:CAS:528:DyaK1MXitFKrs7o%3D 10.1038/7701 (Pubitemid 29159572)
96. MT Baldridge KY King NC Boles DC Weksberg MA Goodell 2010 Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection Nature 465 7299 793 797 20535209 1:CAS:528:DC%2BC3cXntF2mtb8%3D 10.1038/nature09135
97. H Ikeda LJ Old RD Schreiber 2002 The roles of IFN gamma in protection against tumor development and cancer immunoediting Cytokine Growth Factor Rev 13 2 95 109 11900986 1:CAS:528:DC%2BD38XitFWhsrs%3D 10.1016/S1359-6101(01)00038-7 (Pubitemid 34229385)
98. AS Dighe E Richards LJ Old RD Schreiber 1994 Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors Immunity 1 6 447 456 7895156 1:CAS:528:DyaK2cXmt1yntro%3D 10.1016/1074-7613(94)90087-6 (Pubitemid 2142268)
99. DH Kaplan V Shankaran AS Dighe E Stockert M Aguet LJ Old RD Schreiber 1998 Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice Proc Natl Acad Sci USA 95 13 7556 7561 9636188 1:CAS:528:DyaK1cXktFChurk%3D 10.1073/pnas.95.13.7556 (Pubitemid 28293291)
100. SE Street E Cretney MJ Smyth 2001 Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis Blood 97 1 192 197 11133760 1:CAS:528:DC%2BD3MXis1CisA%3D%3D 10.1182/blood.V97.1.192 (Pubitemid 32061260)
101. V Shankaran H Ikeda AT Bruce JM White PE Swanson LJ Old RD Schreiber 2001 IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity Nature 410 6832 1107 1111 11323675 1:CAS:528:DC%2BD3MXjsVCrtr4%3D 10.1038/35074122 (Pubitemid 32391043)
102. Qin Z, Blankenstein T (2004) A cancer immunosurveillance controversy. Nat Immunol 5 (1):3-4 (author reply 4-5)
103. TH Schreiber ER Podack 2009 A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas Br J Cancer 101 3 381 386 19638986 1:CAS:528:DC%2BD1MXpsVKnu7w%3D 10.1038/sj.bjc.6605198
104. RD Schreiber A Celada N Buchmeier 1986 The role of interferon-gamma in the induction of activated macrophages Ann Inst Pasteur Immunol 137C 2 203 206 2425717 1:CAS:528:DyaL28XksVSmtLc%3D 10.1016/S0771-050X(86)80028-6 (Pubitemid 16112494)
105. AS Dighe D Campbell CS Hsieh S Clarke DR Greaves S Gordon KM Murphy RD Schreiber 1995 Tissue-specific targeting of cytokine unresponsiveness in transgenic mice Immunity 3 5 657 666 7584155 1:CAS:528:DyaK2MXps1Oqt70%3D 10.1016/1074-7613(95)90136-1
106. TL Murphy MG Cleveland P Kulesza J Magram KM Murphy 1995 Regulation of interleukin 12 p40 expression through an NF-kappa B half-site Mol Cell Biol 15 10 5258 5267 7565674 1:STN:280:DyaK28%2FgvFGmsg%3D%3D
107. C Carnaud D Lee O Donnars SH Park A Beavis Y Koezuka A Bendelac 1999 Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells J Immunol 163 9 4647 4650 10528160 1:CAS:528:DyaK1MXmvFajsLY%3D (Pubitemid 29501223)
108. G Eberl HR MacDonald 2000 Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells Eur J Immunol 30 4 985 992 10760785 1:CAS:528:DC%2BD3cXislWisr4%3D 10.1002/(SICI)1521-4141(200004)30:4<985::AID- IMMU985>3.0.CO;2-E (Pubitemid 30216213)
109. VP Badovinac AR Tvinnereim JT Harty 2000 Regulation of antigen-specific CD8 + T cell homeostasis by perforin and interferon-gamma Science 290 5495 1354 1358 11082062 1:CAS:528:DC%2BD3cXotlemu74%3D 10.1126/science.290.5495.1354
110. JK Whitmire JT Tan JL Whitton 2005 Interferon-gamma acts directly on CD8 + T cells to increase their abundance during virus infection J Exp Med 201 7 1053 1059 15809350 1:CAS:528:DC%2BD2MXjtFWlsrk%3D 10.1084/jem.20041463 (Pubitemid 40524673)
111. LM Bradley DK Dalton M Croft 1996 A direct role for IFN-gamma in regulation of Th1 cell development J Immunol 157 4 1350 1358 8759714 1:CAS:528:DyaK28XkvFWiur8%3D (Pubitemid 126449071)
112. P Scott 1991 IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis J Immunol 147 9 3149 3155 1833466 1:CAS:528:DyaK38XltVWl
113. I Kryczek M Banerjee P Cheng L Vatan W Szeliga S Wei E Huang E Finlayson D Simeone TH Welling A Chang G Coukos R Liu W Zou 2009 Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments Blood 114 6 1141 1149 19470694 1:CAS:528:DC%2BD1MXhtVSgsbbE 10.1182/blood-2009-03-208249
114. F Fallarino TF Gajewski 1999 Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1 J Immunol 163 8 4109 4113 10510345 1:CAS:528:DyaK1MXmslels70%3D (Pubitemid 29474472)
115. AK Kacha F Fallarino MA Markiewicz TF Gajewski 2000 Cutting edge: spontaneous rejection of poorly immunogenic P1. HTR tumors by Stat6-deficient mice J Immunol 165 11 6024 6028 11086033 1:CAS:528:DC%2BD3cXosFOitLY%3D
116. X Cao K Leonard LI Collins SF Cai JC Mayer JE Payton MJ Walter D Piwnica-Worms RD Schreiber TJ Ley 2009 Interleukin 12 stimulates IFN-gamma-mediated inhibition of tumor-induced regulatory T-cell proliferation and enhances tumor clearance Cancer Res 69 22 8700 8709 19843867 1:CAS:528:DC%2BD1MXhtl2rsbfE 10.1158/0008-5472.CAN-09-1145
117. AD Luster JV Ravetch 1987 Biochemical characterization of a gamma interferon-inducible cytokine (IP-10) J Exp Med 166 4 1084 1097 2443596 1:CAS:528:DyaL1cXitVartA%3D%3D 10.1084/jem.166.4.1084 (Pubitemid 18024248)
118. AD Luster P Leder 1993 IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo J Exp Med 178 3 1057 1065 8350046 1:CAS:528:DyaK3sXlsFyjsr4%3D 10.1084/jem.178.3.1057 (Pubitemid 23260444)
119. W Zou L Chen 2008 Inhibitory B7-family molecules in the tumour microenvironment Nat Rev Immunol 8 6 467 477 18500231 1:CAS:528: DC%2BD1cXmt1Ojt74%3D 10.1038/nri2326 (Pubitemid 351733418)
120. K Wu I Kryczek L Chen W Zou TH Welling 2009 Kupffer cell suppression of CD8 + T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions Cancer Res 69 20 8067 8075 19826049 1:CAS:528: DC%2BD1MXht1ynurfK 10.1158/0008-5472.CAN-09-0901
121. H Wiendl M Mitsdoerffer D Schneider L Chen H Lochmuller A Melms M Weller 2003 Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies FASEB J 17 13 1892 1894 12923066 1:CAS:528:DC%2BD3sXot1Kitr4%3D
122. H Dong SE Strome DR Salomao H Tamura F Hirano DB Flies PC Roche J Lu G Zhu K Tamada VA Lennon E Celis L Chen 2002 Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 8 793 800 12091876 1:CAS:528:DC%2BD38Xls12msLo%3D
123. J Liu A Hamrouni D Wolowiec V Coiteux K Kuliczkowski D Hetuin A Saudemont B Quesnel 2007 Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway Blood 110 1 296 304 17363736 1:CAS:528:DC%2BD2sXnsVaitr4%3D 10.1182/blood-2006-10-051482 (Pubitemid 47026847)
124. A Kondo T Yamashita H Tamura W Zhao T Tsuji M Shimizu E Shinya H Takahashi K Tamada L Chen K Dan K Ogata 2010 Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes Blood 116 7 1124 1131 20472834 1:CAS:528:DC%2BC3cXhtFensbvI 10.1182/blood-2009-12-255125
125. DH Munn MD Sharma JR Lee KG Jhaver TS Johnson DB Keskin B Marshall P Chandler SJ Antonia R Burgess CL Slingluff Jr AL Mellor 2002 Potential regulatory function of human dendritic cells expressing indoleamine 2, 3-dioxygenase Science 297 5588 1867 1870 12228717 1:CAS:528:DC%2BD38Xnt1Shsro%3D 10.1126/science.1073514 (Pubitemid 35024345)
126. JM Carlin EC Borden PM Sondel GI Byrne 1987 Biologic-response-modifier- induced indoleamine 2, 3-dioxygenase activity in human peripheral blood mononuclear cell cultures J Immunol 139 7 2414 2418 2443564 1:CAS:528: DyaL2sXmtFGqsbo%3D (Pubitemid 17152142)
127. W Zou 2005 Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat Rev Cancer 5 4 263 274 15776005 1:CAS:528: DC%2BD2MXivVars7g%3D 10.1038/nrc1586 (Pubitemid 40488632)
128. AL Mellor DH Munn 2008 Creating immune privilege: active local suppression that benefits friends, but protects foes Nat Rev Immunol 8 1 74 80 18064049 1:CAS:528:DC%2BD2sXhsVKrsLnM 10.1038/nri2233
129. AJ Muller JB DuHadaway PS Donover E Sutanto-Ward GC Prendergast 2005 Inhibition of indoleamine 2, 3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy Nat Med 11 3 312 319 15711557 1:CAS:528:DC%2BD2MXhvVSru7c%3D 10.1038/nm1196 (Pubitemid 40460560)
130. MD Sharma B Baban P Chandler DY Hou N Singh H Yagita M Azuma BR Blazar AL Mellor DH Munn 2007 Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2, 3-dioxygenase J Clin Invest 117 9 2570 2582 17710230 1:CAS:528:DC%2BD2sXhtVCms7jJ 10.1172/JCI31911 (Pubitemid 47494358)
131. F Fallarino U Grohmann KW Hwang C Orabona C Vacca R Bianchi ML Belladonna MC Fioretti ML Alegre P Puccetti 2003 Modulation of tryptophan catabolism by regulatory T cells Nat Immunol 4 12 1206 1212 14578884 1:CAS:528: DC%2BD3sXpt1Sntrs%3D 10.1038/ni1003 (Pubitemid 37547898)
132. AJ Muller MD Sharma PR Chandler JB Duhadaway ME Everhart BA Johnson III DJ Kahler J Pihkala AP Soler DH Munn GC Prendergast AL Mellor 2008 Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2, 3 dioxygenase Proc Natl Acad Sci USA 105 44 17073 17078 18952840 1:CAS:528:DC%2BD1cXhtlKlsr7K 10.1073/pnas.0806173105
133. PC Rodriguez AH Zea J DeSalvo KS Culotta J Zabaleta DG Quiceno JB Ochoa AC Ochoa 2003 l-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes J Immunol 171 3 1232 1239 12874210 1:CAS:528:DC%2BD3sXlsFymu7g%3D (Pubitemid 36900052)
134. PC Rodriguez DG Quiceno J Zabaleta B Ortiz AH Zea MB Piazuelo A Delgado P Correa J Brayer EM Sotomayor S Antonia JB Ochoa AC Ochoa 2004 Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses Cancer Res 64 16 5839 5849 15313928 1:CAS:528:DC%2BD2cXmslaks70%3D 10.1158/0008-5472.CAN-04-0465 (Pubitemid 39095585)
135. M Saio S Radoja M Marino AB Frey 2001 Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide J Immunol 167 10 5583 5593 11698429 1:CAS:528:DC%2BD3MXotlamt7o%3D (Pubitemid 33062747)
136. SA Kusmartsev Y Li SH Chen 2000 Gr-1 + myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation J Immunol 165 2 779 785 10878351 1:CAS:528:DC%2BD3cXkvFWisLo%3D (Pubitemid 30484744)
137. MV Liscovsky RP Ranocchia CV Gorlino DO Alignani G Moron BA Maletto MC Pistoresi-Palencia 2009 Interferon-gamma priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages Immunology 128 1 Suppl e159 e169 18800985 10.1111/j.1365-2567.2008.02938.x
138. A Mazzoni V Bronte A Visintin JH Spitzer E Apolloni P Serafini P Zanovello DM Segal 2002 Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism J Immunol 168 2 689 695 11777962 1:CAS:528: DC%2BD38XksFWlsg%3D%3D (Pubitemid 34049569)
139. M Modolell IM Corraliza F Link G Soler K Eichmann 1995 Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines Eur J Immunol 25 4 1101 1104 7537672 1:CAS:528:DyaK2MXltFOmtL4%3D 10.1002/eji.1830250436
140. M Hesse M Modolell AC La Flamme M Schito JM Fuentes AW Cheever EJ Pearce TA Wynn 2001 Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of l-arginine metabolism J Immunol 167 11 6533 6544 11714822 1:CAS:528:DC%2BD3MXovVCiurw%3D (Pubitemid 33081589)
141. LA Norian PC Rodriguez LA O'Mara J Zabaleta AC Ochoa M Cella PM Allen 2009 Tumor-infiltrating regulatory dendritic cells inhibit CD8 + T cell function via l-arginine metabolism Cancer Res 69 7 3086 3094 19293186 1:CAS:528:DC%2BD1MXjvVWitrw%3D 10.1158/0008-5472.CAN-08-2826
142. AH Zea PC Rodriguez MB Atkins C Hernandez S Signoretti J Zabaleta D McDermott D Quiceno A Youmans A O'Neill J Mier AC Ochoa 2005 Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion Cancer Res 65 8 3044 3048 15833831 1:CAS:528:DC%2BD2MXjt1yks7g%3D (Pubitemid 40524582)
143. AC Ochoa AH Zea C Hernandez PC Rodriguez 2007 Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma Clin Cancer Res 13 2 Pt 2 721s 726s 17255300 1:CAS:528:DC%2BD2sXoslSqsQ%3D%3D 10.1158/1078-0432. CCR-06-2197
144. PC Rodriguez AC Ochoa 2008 Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives Immunol Rev 222 180 191 18364002 1:CAS:528:DC%2BD1cXlsFejt78%3D 10.1111/j.1600-065X.2008.00608.x (Pubitemid 351430370)
145. PC Rodriguez MS Ernstoff C Hernandez M Atkins J Zabaleta R Sierra AC Ochoa 2009 Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes Cancer Res 69 4 1553 1560 19201693 1:CAS:528:DC%2BD1MXhslynsb4%3D 10.1158/0008-5472.CAN-08-1921
146. SL Highfill PC Rodriguez Q Zhou CA Goetz BH Koehn R Veenstra PA Taylor A Panoskaltsis-Mortari JS Serody DH Munn J Tolar AC Ochoa BR Blazar 2010 Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13 Blood 116 25 5738 5747 20807889 1:CAS:528:DC%2BC3MXhtFGrsrk%3D 10.1182/blood-2010-06-287839
147. S Ilangumaran R Rottapel 2003 Regulation of cytokine receptor signaling by SOCS1 Immunol Rev 192 196 211 12670405 1:CAS:528:DC%2BD3sXjsVOntLw%3D 10.1034/j.1600-065X.2003.00020.x (Pubitemid 36613333)
148. R Starr M Fuchsberger LS Lau AP Uldrich A Goradia TA Willson AM Verhagen WS Alexander MJ Smyth 2009 SOCS-1 binding to tyrosine 441 of IFN-gamma receptor subunit 1 contributes to the attenuation of IFN-gamma signaling in vivo J Immunol 183 7 4537 4544 19734231 1:CAS:528:DC%2BD1MXhtFGjsL%2FN 10.4049/jimmunol.0901010
149. K Taniguchi M Petersson P Hoglund R Kiessling G Klein K Karre 1987 Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens Proc Natl Acad Sci USA 84 10 3405 3409 3106968 1:CAS:528:DyaL2sXkt1Wktr4%3D 10.1073/pnas.84.10.3405 (Pubitemid 17085412)
150. Cho HI, Lee YR, Celis E (2010) Interferon gamma limits the effectiveness of melanoma peptide vaccines. Blood
151. S Morel F Levy O Burlet-Schiltz F Brasseur M Probst-Kepper AL Peitrequin B Monsarrat R Van Velthoven JC Cerottini T Boon JE Gairin BJ Van den Eynde 2000 Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells Immunity 12 1 107 117 10661410 1:CAS:528:DC%2BD3cXhtVWjtbg%3D 10.1016/S1074-7613(00)80163-6 (Pubitemid 30069219)
152. SJ Gobin PJ van den Elsen 2000 Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G Hum Immunol 61 11 1102 1107 11137213 1:CAS:528:DC%2BD3MXntlWjsA%3D%3D 10.1016/S0198-8859(00)00198-1 (Pubitemid 32043886)
153. MR Zaidi S Davis FP Noonan C Graff-Cherry TS Hawley RL Walker L Feigenbaum E Fuchs L Lyakh HA Young TJ Hornyak H Arnheiter G Trinchieri PS Meltzer EC De Fabo G Merlino 2011 Interferon-gamma links ultraviolet radiation to melanomagenesis in mice Nature 469 7331 548 553 21248750 1:CAS:528: DC%2BC3MXnsFaqtg%3D%3D 10.1038/nature09666
154. V Berner H Liu Q Zhou KL Alderson K Sun JM Weiss TC Back DL Longo BR Blazar RH Wiltrout LA Welniak D Redelman WJ Murphy 2007 IFN-gamma mediates CD4 + T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy Nat Med 13 3 354 360 17334371 1:CAS:528:DC%2BD2sXisVKku7o%3D 10.1038/nm1554 (Pubitemid 46376686)
155. C Garbe K Krasagakis CC Zouboulis K Schroder S Kruger R Stadler CE Orfanos 1990 Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype J Invest Dermatol 95 6 Suppl 231S 237S 2124247 1:CAS:528:DyaK3MXhtF2qtL8%3D 10.1111/1523-1747.ep12875837
156. ET Creagan DL Ahmann HJ Long S Frytak SA Sherwin MN Chang 1987 Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma Cancer Treat Rep 71 9 843 844 3113730 1:STN:280:DyaL2szgtFCquw%3D%3D (Pubitemid 17143070)
157. MS Ernstoff T Trautman CA Davis SD Reich P Witman J Balser S Rudnick JM Kirkwood 1987 A randomized phase I/II study of continuous versus intermittent intravenous interferon gamma in patients with metastatic melanoma J Clin Oncol 5 11 1804 1810 3119786 1:STN:280:DyaL1c%2FmtFCrug%3D%3D (Pubitemid 18020846)
158. WC Kopp JW Smith II CH Ewel WG Alvord C Main PM Guyre RG Steis DL Longo WJ Urba 1993 Immunomodulatory effects of interferon-gamma in patients with metastatic malignant melanoma J Immunother Emphas Tumor Immunol 13 3 181 190 1:STN:280:DyaK3s3ivFClsw%3D%3D (Pubitemid 23093225)
159. L Kowalzick U Weyer P Lange EW Breitbart 1990 Systemic therapy of advanced metastatic malignant melanoma with a combination of fibroblast interferon-beta and recombinant interferon-gamma Dermatologica 181 4 298 303 2127402 1:STN:280:DyaK3M7mtVyjtw%3D%3D 10.1159/000247830
160. FL Meyskens Jr K Kopecky M Samson E Hersh J Macdonald H Jaffe J Crowley C Coltman 1990 Recombinant human interferon gamma: adverse effects in high-risk stage I and II cutaneous malignant melanoma J Natl Cancer Inst 82 12 1071 2112201 (Pubitemid 20204986)
161. FL Meyskens Jr KJ Kopecky CW Taylor RD Noyes RJ Tuthill EM Hersh LG Feun JH Doroshow LE Flaherty VK Sondak 1995 Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a southwest oncology group study J Natl Cancer Inst 87 22 1710 1713 7473820 10.1093/jnci/87.22.1710
162. CM Coughlin KE Salhany MS Gee DC LaTemple S Kotenko X Ma G Gri M Wysocka JE Kim L Liu F Liao JM Farber S Pestka G Trinchieri WM Lee 1998 Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis Immunity 9 1 25 34 9697833 1:CAS:528:DyaK1cXkvF2qsbg%3D 10.1016/S1074-7613(00)80585-3 (Pubitemid 28361292)
163. YE Chin M Kitagawa WC Su ZH You Y Iwamoto XY Fu 1996 Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1 Science 272 5262 719 722 8614832 1:CAS:528:DyaK28Xislamtrs%3D 10.1126/science.272.5262.719
164. JF Bromberg CM Horvath Z Wen RD Schreiber JE Darnell Jr 1996 Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma Proc Natl Acad Sci USA 93 15 7673 7678 8755534 1:CAS:528:DyaK28XksFSrsLc%3D 10.1073/pnas.93.15.7673 (Pubitemid 26277095)
165. C Sgadari AL Angiolillo BW Cherney SE Pike JM Farber LG Koniaris P Vanguri PR Burd N Sheikh G Gupta J Teruya-Feldstein G Tosato 1996 Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo Proc Natl Acad Sci USA 93 24 13791 13796 8943014 1:STN:280: DyaK2s%2FpvVCktg%3D%3D 10.1073/pnas.93.24.13791 (Pubitemid 26424199)
166. DA Arenberg SL Kunkel PJ Polverini SB Morris MD Burdick MC Glass DT Taub MD Iannettoni RI Whyte RM Strieter 1996 Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases J Exp Med 184 3 981 992 9064358 1:CAS:528:DyaK28XlsFamtbg%3D 10.1084/jem.184.3.981
167. C Sgadari JM Farber AL Angiolillo F Liao J Teruya-Feldstein PR Burd L Yao G Gupta C Kanegane G Tosato 1997 Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo Blood 89 8 2635 2643 9108380 1:CAS:528:DyaK2sXisFCju7k%3D (Pubitemid 27172547)
168. CM Coughlin KE Salhany M Wysocka E Aruga H Kurzawa AE Chang CA Hunter JC Fox G Trinchieri WM Lee 1998 Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis J Clin Invest 101 6 1441 1452 9502787 1:CAS:528:DyaK1cXitVWjtbs%3D 10.1172/JCI1555 (Pubitemid 28145262)
169. D Briesemeister D Sommermeyer C Loddenkemper R Loew W Uckert T Blankenstein T Kammertoens 2011 Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis Int J Cancer 128 2 371 378 20333679 1:CAS:528:DC%2BC3cXhsVGrurzF 10.1002/ijc.25350
170. H Groux M Bigler JE de Vries MG Roncarolo 1998 Inhibitory and stimulatory effects of IL-10 on human CD8 + T cells J Immunol 160 7 3188 3193 9531274 1:CAS:528:DyaK1cXitFWnu78%3D (Pubitemid 28164707)